emoxypine succinate has been researched along with heme in 2 studies
| Studies (emoxypine succinate) | Trials (emoxypine succinate) | Recent Studies (post-2010) (emoxypine succinate) | Studies (heme) | Trials (heme) | Recent Studies (post-2010) (heme) |
|---|---|---|---|---|---|
| 310 | 60 | 130 | 19,086 | 115 | 4,781 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maskin, SS; Petrov, VI; Ponomarev, ÉA; Strepetov, NN | 1 |
| Konoplya, AI; Laskov, VB; Shul'ginova, AA | 1 |
2 other study(ies) available for emoxypine succinate and heme
| Article | Year |
|---|---|
[Pharmacological neuroprotection against brain damage in ischemiai/reperfusion experiment].
Topics: Animals; Brain; Drug Combinations; Drug Evaluation, Preclinical; Eosine Yellowish-(YS); Flavin Mononucleotide; Glycine; Hematoxylin; Heme; Hemostasis; Immunohistochemistry; Inosine Diphosphate; Male; Necrosis; Neurons; Neuroprotective Agents; Niacinamide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Picolines; Rats; Rats, Inbred Strains; Reperfusion Injury; Succinates; TNF-Related Apoptosis-Inducing Ligand | 2011 |
[Immune and oxygen disturbances in patients with chronic cerebral ischemia and their correction].
Topics: Adult; Amino Acids; Antioxidants; Brain Ischemia; C-Reactive Protein; Chronic Disease; Complement C1 Inhibitor Protein; Complement Factor H; Complement System Proteins; Cytokines; Drug Therapy, Combination; Female; Heme; Humans; Hydrogen Peroxide; Immunoglobulins; Male; Malondialdehyde; Middle Aged; Nootropic Agents; Picolines; Piracetam | 2015 |